A Study of Olezarsen Administered Subcutaneously to Participants With Severe Hypertriglyceridemia

OlezarsenCompletedCompletedPhase 3Open NCT05552326 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…